News Conference News AHA 2020 Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib Todd Neale November 14, 2020
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
Presentation TCT 2020 TCT 449: Direct Oral Anticoagulants vs. Warfarin Following Left Atrial Appendage Occlusion: A Study-Level Meta-Analysis Presenter: Aravdeep Jhand October 14, 2020
News Daily News Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats Todd Neale July 31, 2020
News Daily News FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion Todd Neale July 22, 2020
News Conference News TVT 2020 Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear Todd Neale June 25, 2020
News Conference News TVT 2020 Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events Michael O'Riordan June 23, 2020
News Conference News HRS 2020 PINNACLE FLX: New-Generation Watchman Has High Closure Rates, Good Safety Todd Neale May 15, 2020
News Conference News ACC 2020 Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair L.A. McKeown April 07, 2020
News Conference News ACC 2020 PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients Yael L. Maxwell March 29, 2020
News Conference News ACC 2020 A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI Todd Neale March 29, 2020
News Opinion Editor's Corner A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out Shelley Wood March 16, 2020
News Daily News Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights Yael L. Maxwell February 28, 2020
News Conference News CRT 2020 Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR L.A. McKeown February 24, 2020